| Literature DB >> 19065000 |
Athanasia Skoura1, Timothy Hla.
Abstract
Lysophospholipid (LP) research has experienced a period of renaissance with the discovery of the lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P) receptors in the late 1990s. Vertebrate LP receptors regulate embryogenesis, vascular development, neurogenesis, uterine development, oocyte survival, immune cell trafficking and inflammatory reactions. LP signaling is important in cancer, autoimmunity and inflammatory diseases. Research on LP biology has contributed to the development of a first-generation S1P receptor modulator that has entered phase III clinical trials for the treatment of multiple sclerosis. Further basic research on LP signaling is anticipated to lead to novel therapeutic tools to combat various human diseases.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19065000 PMCID: PMC2674736 DOI: 10.1194/jlr.R800047-JLR200
Source DB: PubMed Journal: J Lipid Res ISSN: 0022-2275 Impact factor: 5.922